Effect of diphenylhydantoin sodium (dilantin) on myocardial A-V potassium difference.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D001693:Biological Transport, Active; D002297:Cardanolides / Q000633:toxicity; D002462:Cell Membrane / Q000201:enzymology; D004285:Dogs; D005260:Female; D005263:Femoral Artery; D006321:Heart / Q000187:drug effects; D006325:Heart Atria / Q000378:metabolism*; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010042:Ouabain / Q000633:toxicity; D010672:Phenytoin / Q000494:pharmacology*; D011188:Potassium / Q000378:metabolism*
D000889:Anti-Arrhythmia Agents; D002297:Cardanolides; D010042:Ouabain; D010672:Phenytoin; D000251:Adenosine Triphosphatases; D011188:Potassium